Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 1.461
+0.087 (6.33%)
Apr 14, 2026, 5:29 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 577.51 million as of April 14, 2026. Its market cap has increased by 77.97% in one year.
Market Cap
577.51M
Enterprise Value
644.49M
Revenue
71.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.46
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 577.51M, a decrease of -65.41%. That is a compound annual growth rate of -10.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 577.51M | -55.93% |
| Dec 30, 2025 | 1.31B | 291.35% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SynAct Pharma AB | 1.00B |
| Cantargia AB | 974.56M |
| Infant Bacterial Therapeutics AB | 670.20M |
| FluoGuide | 632.72M |
| Corline Biomedical AB | 411.10M |
| Sprint Bioscience AB | 386.19M |
| Ascelia Pharma AB | 376.80M |
| Bio-Works Technologies AB | 344.01M |